nodes	percent_of_prediction	percent_of_DWPC	metapath
Pantoprazole—SLCO1B1—Indinavir—acquired immunodeficiency syndrome	0.0365	0.0501	CbGbCtD
Pantoprazole—SLCO1B1—Nelfinavir—acquired immunodeficiency syndrome	0.0355	0.0486	CbGbCtD
Pantoprazole—SLCO1B1—Saquinavir—acquired immunodeficiency syndrome	0.0321	0.044	CbGbCtD
Pantoprazole—SLCO1B1—Ritonavir—acquired immunodeficiency syndrome	0.0321	0.044	CbGbCtD
Pantoprazole—ABCG2—Nelfinavir—acquired immunodeficiency syndrome	0.0282	0.0386	CbGbCtD
Pantoprazole—ABCG2—Saquinavir—acquired immunodeficiency syndrome	0.0255	0.0349	CbGbCtD
Pantoprazole—ABCG2—Ritonavir—acquired immunodeficiency syndrome	0.0255	0.0349	CbGbCtD
Pantoprazole—ABCG2—Zidovudine—acquired immunodeficiency syndrome	0.0244	0.0335	CbGbCtD
Pantoprazole—ABCG2—Lamivudine—acquired immunodeficiency syndrome	0.0189	0.0259	CbGbCtD
Pantoprazole—CYP2C19—Efavirenz—acquired immunodeficiency syndrome	0.0177	0.0242	CbGbCtD
Pantoprazole—CYP2C19—Lopinavir—acquired immunodeficiency syndrome	0.0166	0.0228	CbGbCtD
Pantoprazole—CYP1A2—Efavirenz—acquired immunodeficiency syndrome	0.0163	0.0223	CbGbCtD
Pantoprazole—CYP1A2—Lopinavir—acquired immunodeficiency syndrome	0.0153	0.021	CbGbCtD
Pantoprazole—CYP1A2—Nevirapine—acquired immunodeficiency syndrome	0.0153	0.021	CbGbCtD
Pantoprazole—CYP2C19—Delavirdine—acquired immunodeficiency syndrome	0.015	0.0206	CbGbCtD
Pantoprazole—CYP2C19—Amprenavir—acquired immunodeficiency syndrome	0.015	0.0206	CbGbCtD
Pantoprazole—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.0147	0.0201	CbGbCtD
Pantoprazole—CYP1A2—Delavirdine—acquired immunodeficiency syndrome	0.0139	0.019	CbGbCtD
Pantoprazole—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.0138	0.0189	CbGbCtD
Pantoprazole—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.0138	0.0189	CbGbCtD
Pantoprazole—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.0134	0.0184	CbGbCtD
Pantoprazole—CYP2C19—Indinavir—acquired immunodeficiency syndrome	0.013	0.0178	CbGbCtD
Pantoprazole—CYP2C19—Nelfinavir—acquired immunodeficiency syndrome	0.0126	0.0173	CbGbCtD
Pantoprazole—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.0125	0.0171	CbGbCtD
Pantoprazole—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.0125	0.0171	CbGbCtD
Pantoprazole—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.0121	0.0166	CbGbCtD
Pantoprazole—CYP1A2—Nelfinavir—acquired immunodeficiency syndrome	0.0116	0.0159	CbGbCtD
Pantoprazole—CYP2C19—Saquinavir—acquired immunodeficiency syndrome	0.0114	0.0156	CbGbCtD
Pantoprazole—CYP2C19—Ritonavir—acquired immunodeficiency syndrome	0.0114	0.0156	CbGbCtD
Pantoprazole—CYP2C19—Zidovudine—acquired immunodeficiency syndrome	0.0109	0.015	CbGbCtD
Pantoprazole—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.0108	0.0148	CbGbCtD
Pantoprazole—CYP1A2—Ritonavir—acquired immunodeficiency syndrome	0.0105	0.0144	CbGbCtD
Pantoprazole—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.0105	0.0143	CbGbCtD
Pantoprazole—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.0105	0.0143	CbGbCtD
Pantoprazole—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.0102	0.0139	CbGbCtD
Pantoprazole—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.00947	0.013	CbGbCtD
Pantoprazole—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.00947	0.013	CbGbCtD
Pantoprazole—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.00919	0.0126	CbGbCtD
Pantoprazole—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.00919	0.0126	CbGbCtD
Pantoprazole—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.00908	0.0124	CbGbCtD
Pantoprazole—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.00881	0.0121	CbGbCtD
Pantoprazole—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.00854	0.0117	CbGbCtD
Pantoprazole—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.00803	0.011	CbGbCtD
Pantoprazole—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.00803	0.011	CbGbCtD
Pantoprazole—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.00726	0.00995	CbGbCtD
Pantoprazole—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.00726	0.00995	CbGbCtD
Pantoprazole—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.00681	0.00934	CbGbCtD
Pantoprazole—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.00627	0.00859	CbGbCtD
Pantoprazole—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.00609	0.00834	CbGbCtD
Pantoprazole—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00551	0.00754	CbGbCtD
Pantoprazole—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00551	0.00754	CbGbCtD
Pantoprazole—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.00528	0.00723	CbGbCtD
Pantoprazole—ATP4A—blood plasma—acquired immunodeficiency syndrome	0.00368	0.124	CbGeAlD
Pantoprazole—ATP4B—digestive system—acquired immunodeficiency syndrome	0.00325	0.11	CbGeAlD
Pantoprazole—SLCO1B1—blood plasma—acquired immunodeficiency syndrome	0.00197	0.0666	CbGeAlD
Pantoprazole—ATP4A—digestive system—acquired immunodeficiency syndrome	0.00141	0.0478	CbGeAlD
Pantoprazole—ATP4A—blood—acquired immunodeficiency syndrome	0.00135	0.0455	CbGeAlD
Pantoprazole—CYP2C19—blood plasma—acquired immunodeficiency syndrome	0.00128	0.0434	CbGeAlD
Pantoprazole—ATP4A—nervous system—acquired immunodeficiency syndrome	0.00109	0.0369	CbGeAlD
Pantoprazole—ATP4A—central nervous system—acquired immunodeficiency syndrome	0.00105	0.0356	CbGeAlD
Pantoprazole—CYP1A2—blood plasma—acquired immunodeficiency syndrome	0.00105	0.0354	CbGeAlD
Pantoprazole—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.000996	0.0336	CbGeAlD
Pantoprazole—ATP4A—brain—acquired immunodeficiency syndrome	0.000836	0.0282	CbGeAlD
Pantoprazole—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000759	0.0256	CbGeAlD
Pantoprazole—SLCO1B1—digestive system—acquired immunodeficiency syndrome	0.000758	0.0256	CbGeAlD
Pantoprazole—SLCO1B1—blood—acquired immunodeficiency syndrome	0.000722	0.0244	CbGeAlD
Pantoprazole—ABCB1—blood plasma—acquired immunodeficiency syndrome	0.000537	0.0182	CbGeAlD
Pantoprazole—CYP2C19—digestive system—acquired immunodeficiency syndrome	0.000494	0.0167	CbGeAlD
Pantoprazole—CYP2C19—blood—acquired immunodeficiency syndrome	0.00047	0.0159	CbGeAlD
Pantoprazole—CYP2C19—vagina—acquired immunodeficiency syndrome	0.000436	0.0147	CbGeAlD
Pantoprazole—CYP1A2—digestive system—acquired immunodeficiency syndrome	0.000403	0.0136	CbGeAlD
Pantoprazole—ABCG2—blood—acquired immunodeficiency syndrome	0.000399	0.0135	CbGeAlD
Pantoprazole—ABCG2—bone marrow—acquired immunodeficiency syndrome	0.000386	0.0131	CbGeAlD
Pantoprazole—ABCG2—spinal cord—acquired immunodeficiency syndrome	0.000385	0.013	CbGeAlD
Pantoprazole—CYP1A2—blood—acquired immunodeficiency syndrome	0.000384	0.013	CbGeAlD
Pantoprazole—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.000383	0.0129	CbGeAlD
Pantoprazole—ABCG2—vagina—acquired immunodeficiency syndrome	0.00037	0.0125	CbGeAlD
Pantoprazole—CYP2C9—blood—acquired immunodeficiency syndrome	0.000365	0.0123	CbGeAlD
Pantoprazole—ABCG2—lung—acquired immunodeficiency syndrome	0.00035	0.0118	CbGeAlD
Pantoprazole—CYP1A2—lung—acquired immunodeficiency syndrome	0.000337	0.0114	CbGeAlD
Pantoprazole—ABCB1—retina—acquired immunodeficiency syndrome	0.000294	0.00994	CbGeAlD
Pantoprazole—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000292	0.00986	CbGeAlD
Pantoprazole—CYP3A4—blood—acquired immunodeficiency syndrome	0.000278	0.0094	CbGeAlD
Pantoprazole—ABCG2—brain—acquired immunodeficiency syndrome	0.000248	0.00837	CbGeAlD
Pantoprazole—ABCG2—lymph node—acquired immunodeficiency syndrome	0.000239	0.00809	CbGeAlD
Pantoprazole—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000226	0.00763	CbGeAlD
Pantoprazole—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000217	0.00734	CbGeAlD
Pantoprazole—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	0.000209	0.00707	CbGeAlD
Pantoprazole—ABCB1—digestive system—acquired immunodeficiency syndrome	0.000207	0.00698	CbGeAlD
Pantoprazole—ABCB1—blood—acquired immunodeficiency syndrome	0.000197	0.00665	CbGeAlD
Pantoprazole—ABCB1—bone marrow—acquired immunodeficiency syndrome	0.000191	0.00644	CbGeAlD
Pantoprazole—ABCB1—spinal cord—acquired immunodeficiency syndrome	0.00019	0.00641	CbGeAlD
Pantoprazole—ABCB1—vagina—acquired immunodeficiency syndrome	0.000183	0.00617	CbGeAlD
Pantoprazole—ABCB1—lung—acquired immunodeficiency syndrome	0.000173	0.00583	CbGeAlD
Pantoprazole—ABCB1—nervous system—acquired immunodeficiency syndrome	0.00016	0.0054	CbGeAlD
Pantoprazole—ABCB1—central nervous system—acquired immunodeficiency syndrome	0.000154	0.0052	CbGeAlD
Pantoprazole—ABCB1—brain—acquired immunodeficiency syndrome	0.000122	0.00413	CbGeAlD
Pantoprazole—ABCB1—lymph node—acquired immunodeficiency syndrome	0.000118	0.00399	CbGeAlD
Pantoprazole—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	7.06e-05	0.000293	CcSEcCtD
Pantoprazole—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	7.03e-05	0.000292	CcSEcCtD
Pantoprazole—Pruritus—Abacavir—acquired immunodeficiency syndrome	7.02e-05	0.000292	CcSEcCtD
Pantoprazole—Fatigue—Indinavir—acquired immunodeficiency syndrome	7.02e-05	0.000292	CcSEcCtD
Pantoprazole—Anorexia—Delavirdine—acquired immunodeficiency syndrome	7.02e-05	0.000292	CcSEcCtD
Pantoprazole—Discomfort—Ritonavir—acquired immunodeficiency syndrome	7.02e-05	0.000292	CcSEcCtD
Pantoprazole—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	7.01e-05	0.000291	CcSEcCtD
Pantoprazole—Cough—Saquinavir—acquired immunodeficiency syndrome	7.01e-05	0.000291	CcSEcCtD
Pantoprazole—Angioedema—Lamivudine—acquired immunodeficiency syndrome	7e-05	0.000291	CcSEcCtD
Pantoprazole—Pain—Indinavir—acquired immunodeficiency syndrome	6.97e-05	0.00029	CcSEcCtD
Pantoprazole—Constipation—Indinavir—acquired immunodeficiency syndrome	6.97e-05	0.00029	CcSEcCtD
Pantoprazole—Insomnia—Efavirenz—acquired immunodeficiency syndrome	6.96e-05	0.000289	CcSEcCtD
Pantoprazole—Urticaria—Zidovudine—acquired immunodeficiency syndrome	6.96e-05	0.000289	CcSEcCtD
Pantoprazole—Convulsion—Saquinavir—acquired immunodeficiency syndrome	6.96e-05	0.000289	CcSEcCtD
Pantoprazole—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	6.95e-05	0.000289	CcSEcCtD
Pantoprazole—Hypertension—Saquinavir—acquired immunodeficiency syndrome	6.93e-05	0.000288	CcSEcCtD
Pantoprazole—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	6.93e-05	0.000288	CcSEcCtD
Pantoprazole—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	6.93e-05	0.000288	CcSEcCtD
Pantoprazole—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	6.92e-05	0.000287	CcSEcCtD
Pantoprazole—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	6.91e-05	0.000287	CcSEcCtD
Pantoprazole—Malaise—Lamivudine—acquired immunodeficiency syndrome	6.91e-05	0.000287	CcSEcCtD
Pantoprazole—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	6.9e-05	0.000287	CcSEcCtD
Pantoprazole—Nausea—Didanosine—acquired immunodeficiency syndrome	6.9e-05	0.000287	CcSEcCtD
Pantoprazole—Vertigo—Lamivudine—acquired immunodeficiency syndrome	6.88e-05	0.000286	CcSEcCtD
Pantoprazole—Hypotension—Delavirdine—acquired immunodeficiency syndrome	6.88e-05	0.000286	CcSEcCtD
Pantoprazole—Syncope—Lamivudine—acquired immunodeficiency syndrome	6.87e-05	0.000286	CcSEcCtD
Pantoprazole—Confusional state—Ritonavir—acquired immunodeficiency syndrome	6.87e-05	0.000285	CcSEcCtD
Pantoprazole—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	6.86e-05	0.000285	CcSEcCtD
Pantoprazole—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	6.86e-05	0.000285	CcSEcCtD
Pantoprazole—Somnolence—Efavirenz—acquired immunodeficiency syndrome	6.84e-05	0.000284	CcSEcCtD
Pantoprazole—Myalgia—Saquinavir—acquired immunodeficiency syndrome	6.84e-05	0.000284	CcSEcCtD
Pantoprazole—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	6.84e-05	0.000284	CcSEcCtD
Pantoprazole—Chest pain—Saquinavir—acquired immunodeficiency syndrome	6.84e-05	0.000284	CcSEcCtD
Pantoprazole—Anxiety—Saquinavir—acquired immunodeficiency syndrome	6.81e-05	0.000283	CcSEcCtD
Pantoprazole—Oedema—Ritonavir—acquired immunodeficiency syndrome	6.81e-05	0.000283	CcSEcCtD
Pantoprazole—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	6.79e-05	0.000282	CcSEcCtD
Pantoprazole—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	6.79e-05	0.000282	CcSEcCtD
Pantoprazole—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	6.78e-05	0.000282	CcSEcCtD
Pantoprazole—Discomfort—Saquinavir—acquired immunodeficiency syndrome	6.76e-05	0.000281	CcSEcCtD
Pantoprazole—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	6.73e-05	0.00028	CcSEcCtD
Pantoprazole—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	6.71e-05	0.000279	CcSEcCtD
Pantoprazole—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	6.71e-05	0.000279	CcSEcCtD
Pantoprazole—Shock—Ritonavir—acquired immunodeficiency syndrome	6.7e-05	0.000278	CcSEcCtD
Pantoprazole—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	6.69e-05	0.000278	CcSEcCtD
Pantoprazole—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	6.69e-05	0.000278	CcSEcCtD
Pantoprazole—Cough—Lamivudine—acquired immunodeficiency syndrome	6.69e-05	0.000278	CcSEcCtD
Pantoprazole—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	6.69e-05	0.000278	CcSEcCtD
Pantoprazole—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	6.68e-05	0.000278	CcSEcCtD
Pantoprazole—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	6.67e-05	0.000277	CcSEcCtD
Pantoprazole—Dizziness—Stavudine—acquired immunodeficiency syndrome	6.66e-05	0.000277	CcSEcCtD
Pantoprazole—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	6.66e-05	0.000277	CcSEcCtD
Pantoprazole—Insomnia—Delavirdine—acquired immunodeficiency syndrome	6.66e-05	0.000277	CcSEcCtD
Pantoprazole—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	6.65e-05	0.000276	CcSEcCtD
Pantoprazole—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	6.65e-05	0.000276	CcSEcCtD
Pantoprazole—Convulsion—Lamivudine—acquired immunodeficiency syndrome	6.64e-05	0.000276	CcSEcCtD
Pantoprazole—Vomiting—Nevirapine—acquired immunodeficiency syndrome	6.64e-05	0.000276	CcSEcCtD
Pantoprazole—Fatigue—Efavirenz—acquired immunodeficiency syndrome	6.64e-05	0.000276	CcSEcCtD
Pantoprazole—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	6.62e-05	0.000275	CcSEcCtD
Pantoprazole—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	6.61e-05	0.000275	CcSEcCtD
Pantoprazole—Confusional state—Saquinavir—acquired immunodeficiency syndrome	6.61e-05	0.000275	CcSEcCtD
Pantoprazole—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	6.58e-05	0.000274	CcSEcCtD
Pantoprazole—Pain—Efavirenz—acquired immunodeficiency syndrome	6.58e-05	0.000274	CcSEcCtD
Pantoprazole—Constipation—Efavirenz—acquired immunodeficiency syndrome	6.58e-05	0.000274	CcSEcCtD
Pantoprazole—Rash—Nevirapine—acquired immunodeficiency syndrome	6.58e-05	0.000274	CcSEcCtD
Pantoprazole—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	6.58e-05	0.000273	CcSEcCtD
Pantoprazole—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	6.57e-05	0.000273	CcSEcCtD
Pantoprazole—Dizziness—Abacavir—acquired immunodeficiency syndrome	6.57e-05	0.000273	CcSEcCtD
Pantoprazole—Oedema—Saquinavir—acquired immunodeficiency syndrome	6.56e-05	0.000272	CcSEcCtD
Pantoprazole—Somnolence—Delavirdine—acquired immunodeficiency syndrome	6.55e-05	0.000272	CcSEcCtD
Pantoprazole—Headache—Nevirapine—acquired immunodeficiency syndrome	6.54e-05	0.000272	CcSEcCtD
Pantoprazole—Chest pain—Lamivudine—acquired immunodeficiency syndrome	6.52e-05	0.000271	CcSEcCtD
Pantoprazole—Myalgia—Lamivudine—acquired immunodeficiency syndrome	6.52e-05	0.000271	CcSEcCtD
Pantoprazole—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	6.52e-05	0.000271	CcSEcCtD
Pantoprazole—Infection—Saquinavir—acquired immunodeficiency syndrome	6.51e-05	0.000271	CcSEcCtD
Pantoprazole—Anxiety—Lamivudine—acquired immunodeficiency syndrome	6.5e-05	0.00027	CcSEcCtD
Pantoprazole—Anorexia—Ritonavir—acquired immunodeficiency syndrome	6.49e-05	0.00027	CcSEcCtD
Pantoprazole—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	6.48e-05	0.000269	CcSEcCtD
Pantoprazole—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	6.48e-05	0.000269	CcSEcCtD
Pantoprazole—Urticaria—Indinavir—acquired immunodeficiency syndrome	6.47e-05	0.000269	CcSEcCtD
Pantoprazole—Shock—Saquinavir—acquired immunodeficiency syndrome	6.45e-05	0.000268	CcSEcCtD
Pantoprazole—Discomfort—Lamivudine—acquired immunodeficiency syndrome	6.45e-05	0.000268	CcSEcCtD
Pantoprazole—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	6.44e-05	0.000268	CcSEcCtD
Pantoprazole—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	6.44e-05	0.000268	CcSEcCtD
Pantoprazole—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	6.43e-05	0.000267	CcSEcCtD
Pantoprazole—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	6.43e-05	0.000267	CcSEcCtD
Pantoprazole—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	6.42e-05	0.000267	CcSEcCtD
Pantoprazole—Vomiting—Stavudine—acquired immunodeficiency syndrome	6.41e-05	0.000266	CcSEcCtD
Pantoprazole—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	6.4e-05	0.000266	CcSEcCtD
Pantoprazole—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	6.38e-05	0.000265	CcSEcCtD
Pantoprazole—Rash—Nelfinavir—acquired immunodeficiency syndrome	6.37e-05	0.000265	CcSEcCtD
Pantoprazole—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	6.37e-05	0.000265	CcSEcCtD
Pantoprazole—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	6.37e-05	0.000265	CcSEcCtD
Pantoprazole—Hypotension—Ritonavir—acquired immunodeficiency syndrome	6.36e-05	0.000264	CcSEcCtD
Pantoprazole—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	6.36e-05	0.000264	CcSEcCtD
Pantoprazole—Rash—Stavudine—acquired immunodeficiency syndrome	6.35e-05	0.000264	CcSEcCtD
Pantoprazole—Fatigue—Delavirdine—acquired immunodeficiency syndrome	6.35e-05	0.000264	CcSEcCtD
Pantoprazole—Dermatitis—Stavudine—acquired immunodeficiency syndrome	6.35e-05	0.000264	CcSEcCtD
Pantoprazole—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	6.34e-05	0.000264	CcSEcCtD
Pantoprazole—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	6.34e-05	0.000263	CcSEcCtD
Pantoprazole—Headache—Nelfinavir—acquired immunodeficiency syndrome	6.33e-05	0.000263	CcSEcCtD
Pantoprazole—Headache—Stavudine—acquired immunodeficiency syndrome	6.31e-05	0.000262	CcSEcCtD
Pantoprazole—Vomiting—Abacavir—acquired immunodeficiency syndrome	6.31e-05	0.000262	CcSEcCtD
Pantoprazole—Confusional state—Lamivudine—acquired immunodeficiency syndrome	6.31e-05	0.000262	CcSEcCtD
Pantoprazole—Pain—Delavirdine—acquired immunodeficiency syndrome	6.3e-05	0.000262	CcSEcCtD
Pantoprazole—Constipation—Delavirdine—acquired immunodeficiency syndrome	6.3e-05	0.000262	CcSEcCtD
Pantoprazole—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	6.29e-05	0.000262	CcSEcCtD
Pantoprazole—Asthenia—Zidovudine—acquired immunodeficiency syndrome	6.29e-05	0.000261	CcSEcCtD
Pantoprazole—Rash—Abacavir—acquired immunodeficiency syndrome	6.26e-05	0.00026	CcSEcCtD
Pantoprazole—Dermatitis—Abacavir—acquired immunodeficiency syndrome	6.25e-05	0.00026	CcSEcCtD
Pantoprazole—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	6.25e-05	0.00026	CcSEcCtD
Pantoprazole—Oedema—Lamivudine—acquired immunodeficiency syndrome	6.25e-05	0.00026	CcSEcCtD
Pantoprazole—Anorexia—Saquinavir—acquired immunodeficiency syndrome	6.25e-05	0.00026	CcSEcCtD
Pantoprazole—Headache—Abacavir—acquired immunodeficiency syndrome	6.22e-05	0.000258	CcSEcCtD
Pantoprazole—Infection—Lamivudine—acquired immunodeficiency syndrome	6.21e-05	0.000258	CcSEcCtD
Pantoprazole—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	6.21e-05	0.000258	CcSEcCtD
Pantoprazole—Nausea—Nevirapine—acquired immunodeficiency syndrome	6.2e-05	0.000258	CcSEcCtD
Pantoprazole—Pruritus—Zidovudine—acquired immunodeficiency syndrome	6.2e-05	0.000258	CcSEcCtD
Pantoprazole—Insomnia—Ritonavir—acquired immunodeficiency syndrome	6.16e-05	0.000256	CcSEcCtD
Pantoprazole—Shock—Lamivudine—acquired immunodeficiency syndrome	6.15e-05	0.000256	CcSEcCtD
Pantoprazole—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	6.13e-05	0.000255	CcSEcCtD
Pantoprazole—Hypotension—Saquinavir—acquired immunodeficiency syndrome	6.13e-05	0.000255	CcSEcCtD
Pantoprazole—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	6.12e-05	0.000254	CcSEcCtD
Pantoprazole—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	6.12e-05	0.000254	CcSEcCtD
Pantoprazole—Urticaria—Efavirenz—acquired immunodeficiency syndrome	6.12e-05	0.000254	CcSEcCtD
Pantoprazole—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	6.08e-05	0.000253	CcSEcCtD
Pantoprazole—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	6.08e-05	0.000253	CcSEcCtD
Pantoprazole—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	6.07e-05	0.000252	CcSEcCtD
Pantoprazole—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	6.07e-05	0.000252	CcSEcCtD
Pantoprazole—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	6.07e-05	0.000252	CcSEcCtD
Pantoprazole—Somnolence—Ritonavir—acquired immunodeficiency syndrome	6.05e-05	0.000252	CcSEcCtD
Pantoprazole—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	6.05e-05	0.000251	CcSEcCtD
Pantoprazole—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	6.02e-05	0.00025	CcSEcCtD
Pantoprazole—Nausea—Nelfinavir—acquired immunodeficiency syndrome	6.01e-05	0.00025	CcSEcCtD
Pantoprazole—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	6e-05	0.000249	CcSEcCtD
Pantoprazole—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	6e-05	0.000249	CcSEcCtD
Pantoprazole—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	5.99e-05	0.000249	CcSEcCtD
Pantoprazole—Nausea—Stavudine—acquired immunodeficiency syndrome	5.99e-05	0.000249	CcSEcCtD
Pantoprazole—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	5.97e-05	0.000248	CcSEcCtD
Pantoprazole—Anorexia—Lamivudine—acquired immunodeficiency syndrome	5.96e-05	0.000248	CcSEcCtD
Pantoprazole—Insomnia—Saquinavir—acquired immunodeficiency syndrome	5.93e-05	0.000246	CcSEcCtD
Pantoprazole—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	5.92e-05	0.000246	CcSEcCtD
Pantoprazole—Nausea—Abacavir—acquired immunodeficiency syndrome	5.9e-05	0.000245	CcSEcCtD
Pantoprazole—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	5.89e-05	0.000245	CcSEcCtD
Pantoprazole—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	5.88e-05	0.000244	CcSEcCtD
Pantoprazole—Fatigue—Ritonavir—acquired immunodeficiency syndrome	5.87e-05	0.000244	CcSEcCtD
Pantoprazole—Urticaria—Delavirdine—acquired immunodeficiency syndrome	5.85e-05	0.000243	CcSEcCtD
Pantoprazole—Asthenia—Indinavir—acquired immunodeficiency syndrome	5.85e-05	0.000243	CcSEcCtD
Pantoprazole—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	5.84e-05	0.000243	CcSEcCtD
Pantoprazole—Hypotension—Lamivudine—acquired immunodeficiency syndrome	5.84e-05	0.000243	CcSEcCtD
Pantoprazole—Somnolence—Saquinavir—acquired immunodeficiency syndrome	5.83e-05	0.000242	CcSEcCtD
Pantoprazole—Constipation—Ritonavir—acquired immunodeficiency syndrome	5.82e-05	0.000242	CcSEcCtD
Pantoprazole—Pain—Ritonavir—acquired immunodeficiency syndrome	5.82e-05	0.000242	CcSEcCtD
Pantoprazole—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	5.82e-05	0.000242	CcSEcCtD
Pantoprazole—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	5.82e-05	0.000242	CcSEcCtD
Pantoprazole—Dizziness—Zidovudine—acquired immunodeficiency syndrome	5.79e-05	0.000241	CcSEcCtD
Pantoprazole—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	5.77e-05	0.00024	CcSEcCtD
Pantoprazole—Pruritus—Indinavir—acquired immunodeficiency syndrome	5.76e-05	0.00024	CcSEcCtD
Pantoprazole—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	5.7e-05	0.000237	CcSEcCtD
Pantoprazole—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	5.7e-05	0.000237	CcSEcCtD
Pantoprazole—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	5.67e-05	0.000236	CcSEcCtD
Pantoprazole—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	5.66e-05	0.000235	CcSEcCtD
Pantoprazole—Insomnia—Lamivudine—acquired immunodeficiency syndrome	5.66e-05	0.000235	CcSEcCtD
Pantoprazole—Fatigue—Saquinavir—acquired immunodeficiency syndrome	5.65e-05	0.000235	CcSEcCtD
Pantoprazole—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	5.62e-05	0.000233	CcSEcCtD
Pantoprazole—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	5.61e-05	0.000233	CcSEcCtD
Pantoprazole—Constipation—Saquinavir—acquired immunodeficiency syndrome	5.61e-05	0.000233	CcSEcCtD
Pantoprazole—Pain—Saquinavir—acquired immunodeficiency syndrome	5.61e-05	0.000233	CcSEcCtD
Pantoprazole—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	5.58e-05	0.000232	CcSEcCtD
Pantoprazole—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	5.57e-05	0.000232	CcSEcCtD
Pantoprazole—Vomiting—Zidovudine—acquired immunodeficiency syndrome	5.57e-05	0.000231	CcSEcCtD
Pantoprazole—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	5.57e-05	0.000231	CcSEcCtD
Pantoprazole—Somnolence—Lamivudine—acquired immunodeficiency syndrome	5.56e-05	0.000231	CcSEcCtD
Pantoprazole—Rash—Zidovudine—acquired immunodeficiency syndrome	5.52e-05	0.00023	CcSEcCtD
Pantoprazole—Asthenia—Efavirenz—acquired immunodeficiency syndrome	5.52e-05	0.00023	CcSEcCtD
Pantoprazole—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	5.52e-05	0.000229	CcSEcCtD
Pantoprazole—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	5.5e-05	0.000229	CcSEcCtD
Pantoprazole—Headache—Zidovudine—acquired immunodeficiency syndrome	5.49e-05	0.000228	CcSEcCtD
Pantoprazole—Pruritus—Efavirenz—acquired immunodeficiency syndrome	5.45e-05	0.000226	CcSEcCtD
Pantoprazole—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	5.44e-05	0.000226	CcSEcCtD
Pantoprazole—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	5.43e-05	0.000225	CcSEcCtD
Pantoprazole—Urticaria—Ritonavir—acquired immunodeficiency syndrome	5.41e-05	0.000225	CcSEcCtD
Pantoprazole—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	5.4e-05	0.000224	CcSEcCtD
Pantoprazole—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	5.4e-05	0.000224	CcSEcCtD
Pantoprazole—Fatigue—Lamivudine—acquired immunodeficiency syndrome	5.39e-05	0.000224	CcSEcCtD
Pantoprazole—Dizziness—Indinavir—acquired immunodeficiency syndrome	5.39e-05	0.000224	CcSEcCtD
Pantoprazole—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	5.38e-05	0.000224	CcSEcCtD
Pantoprazole—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	5.38e-05	0.000224	CcSEcCtD
Pantoprazole—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	5.36e-05	0.000223	CcSEcCtD
Pantoprazole—Pain—Lamivudine—acquired immunodeficiency syndrome	5.35e-05	0.000222	CcSEcCtD
Pantoprazole—Constipation—Lamivudine—acquired immunodeficiency syndrome	5.35e-05	0.000222	CcSEcCtD
Pantoprazole—Asthenia—Delavirdine—acquired immunodeficiency syndrome	5.28e-05	0.00022	CcSEcCtD
Pantoprazole—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	5.27e-05	0.000219	CcSEcCtD
Pantoprazole—Pruritus—Delavirdine—acquired immunodeficiency syndrome	5.21e-05	0.000217	CcSEcCtD
Pantoprazole—Urticaria—Saquinavir—acquired immunodeficiency syndrome	5.21e-05	0.000216	CcSEcCtD
Pantoprazole—Nausea—Zidovudine—acquired immunodeficiency syndrome	5.2e-05	0.000216	CcSEcCtD
Pantoprazole—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	5.18e-05	0.000215	CcSEcCtD
Pantoprazole—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	5.18e-05	0.000215	CcSEcCtD
Pantoprazole—Vomiting—Indinavir—acquired immunodeficiency syndrome	5.18e-05	0.000215	CcSEcCtD
Pantoprazole—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	5.15e-05	0.000214	CcSEcCtD
Pantoprazole—Rash—Indinavir—acquired immunodeficiency syndrome	5.14e-05	0.000213	CcSEcCtD
Pantoprazole—Dermatitis—Indinavir—acquired immunodeficiency syndrome	5.13e-05	0.000213	CcSEcCtD
Pantoprazole—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	5.11e-05	0.000213	CcSEcCtD
Pantoprazole—Headache—Indinavir—acquired immunodeficiency syndrome	5.1e-05	0.000212	CcSEcCtD
Pantoprazole—Dizziness—Efavirenz—acquired immunodeficiency syndrome	5.09e-05	0.000212	CcSEcCtD
Pantoprazole—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	5.04e-05	0.000209	CcSEcCtD
Pantoprazole—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	5.02e-05	0.000209	CcSEcCtD
Pantoprazole—Urticaria—Lamivudine—acquired immunodeficiency syndrome	4.97e-05	0.000206	CcSEcCtD
Pantoprazole—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	4.94e-05	0.000205	CcSEcCtD
Pantoprazole—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	4.94e-05	0.000205	CcSEcCtD
Pantoprazole—Vomiting—Efavirenz—acquired immunodeficiency syndrome	4.89e-05	0.000203	CcSEcCtD
Pantoprazole—Asthenia—Ritonavir—acquired immunodeficiency syndrome	4.89e-05	0.000203	CcSEcCtD
Pantoprazole—Dizziness—Delavirdine—acquired immunodeficiency syndrome	4.87e-05	0.000202	CcSEcCtD
Pantoprazole—Rash—Efavirenz—acquired immunodeficiency syndrome	4.85e-05	0.000202	CcSEcCtD
Pantoprazole—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	4.85e-05	0.000202	CcSEcCtD
Pantoprazole—Nausea—Indinavir—acquired immunodeficiency syndrome	4.84e-05	0.000201	CcSEcCtD
Pantoprazole—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	4.83e-05	0.000201	CcSEcCtD
Pantoprazole—Headache—Efavirenz—acquired immunodeficiency syndrome	4.82e-05	0.0002	CcSEcCtD
Pantoprazole—Pruritus—Ritonavir—acquired immunodeficiency syndrome	4.82e-05	0.0002	CcSEcCtD
Pantoprazole—Asthenia—Saquinavir—acquired immunodeficiency syndrome	4.7e-05	0.000195	CcSEcCtD
Pantoprazole—Vomiting—Delavirdine—acquired immunodeficiency syndrome	4.68e-05	0.000195	CcSEcCtD
Pantoprazole—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	4.66e-05	0.000194	CcSEcCtD
Pantoprazole—Rash—Delavirdine—acquired immunodeficiency syndrome	4.64e-05	0.000193	CcSEcCtD
Pantoprazole—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	4.64e-05	0.000193	CcSEcCtD
Pantoprazole—Pruritus—Saquinavir—acquired immunodeficiency syndrome	4.64e-05	0.000193	CcSEcCtD
Pantoprazole—Headache—Delavirdine—acquired immunodeficiency syndrome	4.61e-05	0.000192	CcSEcCtD
Pantoprazole—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	4.61e-05	0.000191	CcSEcCtD
Pantoprazole—Nausea—Efavirenz—acquired immunodeficiency syndrome	4.57e-05	0.00019	CcSEcCtD
Pantoprazole—Dizziness—Ritonavir—acquired immunodeficiency syndrome	4.5e-05	0.000187	CcSEcCtD
Pantoprazole—Asthenia—Lamivudine—acquired immunodeficiency syndrome	4.49e-05	0.000186	CcSEcCtD
Pantoprazole—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	4.49e-05	0.000186	CcSEcCtD
Pantoprazole—Pruritus—Lamivudine—acquired immunodeficiency syndrome	4.42e-05	0.000184	CcSEcCtD
Pantoprazole—Nausea—Delavirdine—acquired immunodeficiency syndrome	4.37e-05	0.000182	CcSEcCtD
Pantoprazole—Dizziness—Saquinavir—acquired immunodeficiency syndrome	4.33e-05	0.00018	CcSEcCtD
Pantoprazole—Vomiting—Ritonavir—acquired immunodeficiency syndrome	4.33e-05	0.00018	CcSEcCtD
Pantoprazole—Rash—Ritonavir—acquired immunodeficiency syndrome	4.29e-05	0.000178	CcSEcCtD
Pantoprazole—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	4.29e-05	0.000178	CcSEcCtD
Pantoprazole—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	4.28e-05	0.000178	CcSEcCtD
Pantoprazole—Headache—Ritonavir—acquired immunodeficiency syndrome	4.27e-05	0.000177	CcSEcCtD
Pantoprazole—Vomiting—Saquinavir—acquired immunodeficiency syndrome	4.17e-05	0.000173	CcSEcCtD
Pantoprazole—Dizziness—Lamivudine—acquired immunodeficiency syndrome	4.14e-05	0.000172	CcSEcCtD
Pantoprazole—Rash—Saquinavir—acquired immunodeficiency syndrome	4.13e-05	0.000172	CcSEcCtD
Pantoprazole—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	4.13e-05	0.000172	CcSEcCtD
Pantoprazole—Headache—Saquinavir—acquired immunodeficiency syndrome	4.11e-05	0.000171	CcSEcCtD
Pantoprazole—Nausea—Ritonavir—acquired immunodeficiency syndrome	4.05e-05	0.000168	CcSEcCtD
Pantoprazole—Vomiting—Lamivudine—acquired immunodeficiency syndrome	3.98e-05	0.000165	CcSEcCtD
Pantoprazole—Rash—Lamivudine—acquired immunodeficiency syndrome	3.94e-05	0.000164	CcSEcCtD
Pantoprazole—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	3.94e-05	0.000164	CcSEcCtD
Pantoprazole—Headache—Lamivudine—acquired immunodeficiency syndrome	3.92e-05	0.000163	CcSEcCtD
Pantoprazole—Nausea—Saquinavir—acquired immunodeficiency syndrome	3.89e-05	0.000162	CcSEcCtD
Pantoprazole—Nausea—Lamivudine—acquired immunodeficiency syndrome	3.71e-05	0.000154	CcSEcCtD
